Renoprotection byα-mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity

Free Radical Research

Volumn 43, Issue 11, 2009, Pages 1122-1132

  Pérez Rojas, Jazmin M ^a   Cruz, Cristino ^b   García López, Patricia ^c   Sánchez González, Dolores J ^d   Martínez Martínez, Claudia M ^d   Ceballos, Gisela ^e   Espinosa, Magali ^e   Meléndez Zajgla, Jorge ^e   Pedraza Chaverri, Jos ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^d Laboratorio de Biología Celular y Tisular   (Mexico)

^e INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

Alpha mangostin; Anti inflammatory; Antioxidant; Catalase; Cisplatin; Oxidative stress

Indexed keywords

ALPHA MANGOSTIN; ANTIOXIDANT; CATALASE; CISPLATIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MANGOSTIN; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; KIDNEY DYSFUNCTION; MALE; MAXIMUM PLASMA CONCENTRATION; NEPHROTOXICITY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; CHEMICALLY INDUCED; DNA MICROARRAY; DRUG EFFECTS; DRUG INTERACTION; KIDNEY DISEASES; METABOLISM; TOXICITY; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; DRUG INTERACTIONS; KIDNEY DISEASES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; RATS; RATS, WISTAR; XANTHONES;

GARCINIA MANGOSTANA; RATTUS;

EID: 70350532742     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760903214447     Document Type: Article

References (28)

1. Cohen SM, Lippard SJ. Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol 2001;67:93-130
2. Lebwohl D Canetta R: Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998;34:1522-1534
3. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 2003;23:460-464
4. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 2009;61:223-242
5. Shino Y, Itoh Y, Kubota T, Yano T, Sendo T, Oishi R. Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells. Free Radic Biol Med 2003;35:966-977
6. Levi J, Jacobs C, Kalman SM, McTigue M, Weiner MW. Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys. J Pharmacol Exp Ther 1980;213:545-550
7. Yano T, Itoh Y, Matsuo M, Kawashiri T, Egashira N, Oishi R. Involvement of both tumor necrosis factor-alpha-induced necrosis and p53-mediated caspase-dependent apoptosis in nephrotoxicity of cisplatin. Apoptosis 2007;12:1901-1909
8. Vijayan FP, Rani VK, Vineesh VR, Sudha KS, Michael MM, Padikkala J. Protective effect of Cyclea peltata Lam on cisplatin-induced nephrotoxicity and oxidative damage. J Basic Clin Physiol Pharmacol 2007;18:101-114
9. Guzman-Beltran S, Orozco-Ibarra M, Gonzalez-Cuahuten-cos O, Victoria-Mares S, Merchand-Reyes G, Medina-Campos ON, Pedraza-Chaverri J. Neuroprotective effect and reactive oxygen species scavenging capacity of mangosteen pericarp extract in cultured neurons. Curr Top Nutraceut Res 2009;6:149-158
10. Pedraza-Chaverri J, Cardenas-Rodriguez N, Orozco-Ibarra M, Perez-Rojas JM. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol 2008;46: 3227-3239
11. Devi Sampath P, Vijayaraghavan K. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2007;21: 336-339
12. Chen LG, Yang LL, Wang CC. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol 2008;46:688-693
13. Tewtrakul S, Wattanapiromsakul C, Mahabusarakam W. Effects of compounds from Garcinia mangostana on inflammatory mediators in RAW264.7 macrophage cells. J Ethno-pharmacol 2009;121:379-382
14. Pedraza-Chaverri J, Reyes-Fermin LM, Nolasco-Amaya EG, Orozco-Ibarra M, Medina-Campos ON, Gonzalez-Cuahu-tencos O, Rivero-Cruz I, Mata R. ROS scavenging capacity and neuroprotective effect of alpha-mangostin against 3-nitropropionic acid in cerebellar granule neurons. Exp Toxicol Pathol 2009;61:491-501
15. Marquez-Valadez B, Lugo-Huitron R, Valdivia-Cerda V, Miranda-Ramirez LR, Perez-De La Cruz V, Gonzalez-Cuahutencos O, Rivero-Cruz I, Mata R, Santamaria A, Pedraza-Chaverri J. The natural xanthone alpha-mangostin reduces oxidative damage in rat brain tissue. Nutr Neurosci 2009;12:35-42
16. Animal environmental, housing, and management. In: Institute of Laboratory Animal Resources, Commission of Life Sciences and National Research Council. Guide for the Care and Use of Laboratory Animals 1 ed. Washington, DC; 1996. p 21-55
17. Maldonado PD, Barrera D, Rivero I, Mata R, Medina-Campos ON, Hernandez-Pando R, Pedraza-Chaverri J. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic Biol Med 2003;35:317-324 (Pubitemid 37288932)
18. Gerard-Monnier D, Erdelmeier I, Regnard K, Moze-Henry N, Yadan JC, Chaudiere J. Reactions of 1-methyl-2-pheny-lindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 1998;11:1176-1183 (Pubitemid 28500798)
19. Fernandez-Checa JC, Kaplowitz N. The use of monochlor-obimane to determine hepatic GSH levels and synthesis. Anal Biochem 1990;190:212-219
20. Chirino YI, Trujillo J, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Cruz C, Bobadilla NA, Pedraza-Chaverri J. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett 2008;176:48-57
21. Chirino YI, Hernandez-Pando R, Pedraza-Chaverri J. Perox-ynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol 2004;4:20
22. Pabla N Dong Z Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008;73:994-1007
23. Mahabusarakam W, Proudfoot J, Taylor W, Croft K. Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin. Free Radic Res 2000;33:643-659
24. Jung HA, Su BN, Keller WJ, Mehta RG, Kinghorn AD. Antioxidant xanthones from the pericarp of Garcinia man-gostana (Mangosteen). J Agric Food Chem 2006;54:2077-2082
25. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromo-benzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974;11:151-169
26. Ali BH, Al Moundhri MS, Tag EM, Nemmar A, Tanira MO. The ameliorative effect of cysteine prodrug L-2-oxothiazoli-dine-4-carboxylic acid on cisplatin-induced nephrotoxicity in rats. Fundam Clin Pharmacol 2007;21:547-553
27. Pan H, Mukhopadhyay P, Rajesh M, Patel V, Mukhopadhyay B, Gao B, Hasko G, Pacher P. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/ni-trosative stress, inflammation, and cell death. J Pharmacol Exp Ther 2009;328:708-714
28. Yamate J, Sato K, Ide M, Nakanishi M, Kuwamura M, Sakuma S, Nakatsuji S. Participation of different macrophage populations and myofibroblastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats. Vet Pathol 2002;39:322-333.